Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders

被引：8

作者：

Bagnasco, Diego ^{[1
,2
]}

Nicola, Stefania ^{[3
]}

Testino, Elisa ^{[1
,2
]}

Brussino, Luisa ^{[3
]}

Pini, Laura ^{[4
]}

Caminati, Marco ^{[5
]}

Piccardo, Federica ^{[2
]}

Canevari, Rikki Frank ^{[6
]}

Melissari, Laura ^{[1
,2
]}

Ioppi, Alessandro ^{[6
]}

Guastini, Luca ^{[6
]}

Lombardi, Carlo ^{[7
]}

Milanese, Manlio ^{[8
]}

Losa, Francesca ^{[9
]}

Robbiano, Michela ^{[1
,2
]}

De Ferrari, Laura ^{[1
,2
]}

Riccio, Anna Maria ^{[1
,2
]}

Guida, Giuseppe ^{[10
]}

Bonavia, Marco ^{[11
]}

Fini, Donatella ^{[12
]}

Balbi, Francesco ^{[13
]}

Caruso, Cristiano ^{[14
]}

Paggiaro, Pierluigi ^{[15
]}

Blasi, Francesco ^{[16
,17
,18
]}

Heffler, Enrico ^{[19
,20
]}

Paoletti, Giovanni ^{[19
,20
]}

Canonica, Giorgio Walter ^{[19
,20
]}

Senna, Gianenrico ^{[5
]}

Passalacqua, Giovanni ^{[1
,2
]}

机构：

[1] Univ Genoa, IRCCS Policlin San Martino, Allergy & Resp Dis, I-16132 Genoa, Italy

[2] Univ Genoa, Dept Internal Med DIMI, I-16132 Genoa, Italy

[3] AO Ordine Mauriziano Torino, SCDU Immunol & Allergol, Cso Re Umberto 109, I-10128 Turin, Italy

[4] Spedali Civili Brescia, Resp Med Unit, Piazzale Spedali Civili 1, I-25123 Brescia, Italy

[5] Univ Verona, Dept Med, I-37134 Verona, Italy

[6] Univ Genoa, ENT Dept, IRCCS Policlin San Martino, I-16132 Genoa, Italy

[7] Fdn Poliambulanza, Dept Unit Allergol Immunol & Pulm Dis, I-25124 Brescia, Italy

[8] ASL2, S Corona Hosp, Dept Resp Dis, I-17027 Pietra Ligure, Italy

[9] ASST Mantova, UO Allergol & Clin Immunol, I-46100 Mantua, Italy

[10] Univ Torino, Dept Clin & Biol Sci, Orbassano 10043, Italy

[11] ASL3, Hosp Ge Arenzano, Dept Rehabil Pulmonol, I-16149 Genoa, Italy

[12] Hosp Sarzana SP, Dept Pneumol, I-19125 La Spezia, Italy

[13] Hosp Imperia, Dept Pneumol, I-18100 Imperia, Italy

[14] Univ Cattolica Sacro Cuore, Dept Med & Surg Sci, Fdn Universitary Policlin A Gemelli IRCCS, I-20123 Rome, Italy

[15] Univ Pisa, Dept Surg Med & Mol Pathol & Crit Care, I-56126 Pisa, Italy

[16] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy

[17] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Resp Unit, I-20122 Milan, Italy

[18] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Adult Cyst Fibrosis Ctr, Internal Med Dept, I-20122 Milan, Italy

[19] IRCCS Human Clin & Res Hosp, Unit Personalized Med Asthma & Allergy, I-20089 Rozzano, Italy

[20] Humanitas Univ, Dept Biomed Sci, I-20072 Pieve Emanuele, Italy

来源：

BIOMEDICINES | 2023年 / 11卷 / 09期

关键词：

severe asthma; eosinophils; mepolizumab; CRSwNP; IL-5; real life; registry; SEVERE EOSINOPHILIC ASTHMA; MULTICENTER;

D O I：

10.3390/biomedicines11092424

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The efficacy mepolizumab in severe asthmatic patients is proven in the literature. Primarily to study the effect of mepolizumab on exacerbations, steroid dependence, and the continuation of efficacy in the long term. Secondarily to evaluate the effect of the drug on nasal polyps. Analyzing data from SANI (Severe Asthma Network Italy) clinics, we observed severe asthmatic patients treated with mepolizumab 100 mg/4 weeks, for a period of 3 years. 157 patients were observed. Exacerbations were reduced from the first year (-84.6%) and progressively to 90 and 95% in the second and third ones. Steroid-dependent patients decreased from 54% to 21% and subsequently to 11% in the second year and 6% in the third year. Patients with concomitant nasal polyps, assessed by SNOT-22, showed a 49% reduction in value from baseline to the third year. The study demonstrated the long-term efficacy of mepolizumab in a real-life setting.

引用

页数：10

共 50 条

[21] Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
Ozgur, Eylem Sercan
Ozge, Cengiz
Ilvan, Ahmet
Nayci, Sibel Atis
JOURNAL OF ASTHMA, 2013, 50 (06) : 687 - 694
[22] Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic "Overlap" severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
Tepetam, Fatma Merve
Akyildiz, Ali Burkan
Ozden, Seyma
Orcen, Cihan
Yakut, Tugce
Atik, Ozge
MEDICINE, 2023, 102 (18) : E33660
[23] Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
Moore, Wendy C.
Kornmann, Oliver
Humbert, Marc
Poirier, Claude
Bel, Elisabeth H.
Kaneko, Norihiro
Smith, Steven G.
Martin, Neil
Gilson, Martyn J.
Price, Robert G.
Bradford, Eric S.
Liu, Mark C.
EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (01)
[24] Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience
Matucci, Andrea
Vivarelli, Emanuele
Bormioli, Susanna
Francesca, Nencini
Chiccoli, Fabio
Valentina, Mecheri
Francesca, Grosso
Oliviero, Rossi
Parronchi, Paola
Vultaggio, Alessandra
JOURNAL OF ASTHMA, 2023, 60 (01) : 158 - 166
[25] Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study
Johannes Anthon Kroes
Sander Wilhelm Zielhuis
Akke-Nynke van der Meer
Kim de Jong
Anneke ten Brinke
Eric Nico van Roon
International Journal of Clinical Pharmacy, 2022, 44 : 570 - 574
[26] Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study
Kroes, Johannes Anthon
Zielhuis, Sander Wilhelm
Van der Meer, Akke-Nynke
de Jong, Kim
ten Brinke, Anneke
van Roon, Eric Nico
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (02) : 570 - 574
[27] Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
Adachi, Mitsuru
Kozawa, Masanari
Yoshisue, Hajime
Milligan, Ki Lee
Nagasaki, Makoto
Sasajima, Takayoshi
Miyamoto, Terumasa
Ohta, Ken
RESPIRATORY MEDICINE, 2018, 141 : 56 - 63
[28] Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
Murphy, Kevin
Jacobs, Joshua
Bjermer, Leif
Fahrenholz, John M.
Shalit, Yael
Garin, Margaret
Zangrilli, James
Castro, Mario
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06) : 1572 - +
[29] What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical Practice
Talamonti, Marina
Galluzzo, Marco
Bianchi, Luca
Boca, Andreea N.
Costanzo, Antonio
Chimenti, Sergio
DERMATOLOGY, 2014, 229 (04) : 324 - 332
[30] Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
Chen, Wenjia
Tran, Trung N.
Sadatsafavi, Mohsen
Murray, Ruth
Wong, Nigel Chong Boon
Ali, Nasloon
Ariti, Con
Bulathsinhala, Lakmini
Garcia, Esther
FitzGerald, J. Mark
Alacqua, Marianna
Al-Ahmad, Mona
Altraja, Alan
Al-Lehebi, Riyad
Bhutani, Mohit
Bjermer, Leif
Bjerrum, Anne-Sofie
Bourdin, Arnaud
von Bulow, Anna
Busby, John
Canonica, Giorgio Walter
Carter, Victoria
Christoff, George C.
Cosio, Borja G.
Costello, Richard W.
Fonseca, Joao A.
Gibson, Peter G.
Yoo, Kwang-Ha
Heaney, Liam G.
Heffler, Enrico
Hew, Mark
Hilberg, Ole
Hoyte, Flavia
Iwanaga, Takashi
Jackson, David J.
Jones, Rupert C.
Koh, Mariko Siyue
Kuna, Piotr
Larenas-Linnemann, Desiree
Lehmann, Sverre
Lehtimaki, Lauri
Lyu, Juntao
Mahboub, Bassam
Maspero, Jorge
Menzies-Gow, Andrew N.
Newell, Anthony
Sirena, Concetta
Papadopoulos, Nikolaos G.
Papaioannou, Andriana I.
Perez-de-Llano, Luis
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09) : 2732 - 2747

← 1 2 3 4 5 →